Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
03/16/2023 | Viracta Therapeutics, Inc. | VIRX | Grant | Stock Option (Right to Buy) | 150k | $1.65 | $247.5k | | 03/16/2023 |
02/27/2023 | Viracta Therapeutics, Inc. | VIRX | Sale | Common Stock | 2.2k | $1.68 | $3.6k | | 02/25/2023 |
02/25/2023 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 4.1k | $0.00 | $0 | | 02/25/2023 |
11/28/2022 | Viracta Therapeutics, Inc. | VIRX | Sale | Common Stock | 2.1k | $2.72 | $5.8k | | 11/25/2022 |
11/25/2022 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 4.1k | $0.00 | $0 | | 11/25/2022 |
08/26/2022 | Viracta Therapeutics, Inc. | VIRX | Sale | Common Stock | 2.2k | $4.01 | $8.8k | | 08/25/2022 |
08/25/2022 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 4.1k | $0.00 | $0 | | 08/25/2022 |
05/26/2022 | Viracta Therapeutics, Inc. | VIRX | Sale | Common Stock | 2.2k | $1.90 | $4.1k | | 05/25/2022 |
05/25/2022 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 4.1k | $0.00 | $0 | | 05/25/2022 |
03/17/2022 | Viracta Therapeutics, Inc. | VIRX | Grant | Stock Option (Right to Buy) | 150k | $3.04 | $456k | | 03/17/2022 |
02/28/2022 | Viracta Therapeutics, Inc. | VIRX | Sale | Common Stock | 2.4k | $2.78 | $6.7k | | 02/25/2022 |
02/25/2022 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 4.1k | $0.00 | $0 | | 02/25/2022 |
11/29/2021 | Viracta Therapeutics, Inc. | VIRX | Sale | Common Stock | 2.6k | $4.82 | $12.5k | | 11/25/2021 |
11/26/2021 | Viracta Therapeutics, Inc. | VIRX | Sale | Common Stock | 2k | $4.80 | $9.4k | | 11/25/2021 |
11/25/2021 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 8.3k | $0.00 | $0 | | 11/25/2021 |
05/11/2021 | Viracta Therapeutics, Inc. | VIRX | Exercise | Stock Option (Right to Buy) | 32.7k | $1.26 | $41.2k | | 05/11/2021 |
05/11/2021 | Viracta Therapeutics, Inc. | VIRX | Exercise | Stock Option (Right to Buy) | 2.1k | $3.58 | $7.4k | | 05/11/2021 |
03/26/2021 | Viracta Therapeutics, Inc. | VIRX | Grant | Stock Option (Right to Buy) | 126.9k | $8.74 | $1.1M | | 03/26/2021 |